FDA Expects Increasing Flow Of Adverse Event Reports
Executive Summary
FDA expects the Center for Drug Evaluation & Research to receive 17% more adverse reaction reports in fiscal year 2006 than it received in FY 2004
You may also be interested in...
Serious Adverse Event Periodic Reporting Increased 20% In 2004, FDAer Says
Serious adverse event periodic reports received by the Center for Drug Evaluation & Research increased 20% in 2004, FDA Investigator Thomas Berry said
Serious Adverse Event Periodic Reporting Increased 20% In 2004, FDAer Says
Serious adverse event periodic reports received by the Center for Drug Evaluation & Research increased 20% in 2004, FDA Investigator Thomas Berry said
FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next
HHS is planning a major overhaul of FDA's postmarketing surveillance system as the centerpiece of its next announcement about upgrades to the drug safety regulatory system